Drug profile · INN
carbidopa
CARBIDOPA AND LEVODOPA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
carbidopa (CARBIDOPA AND LEVODOPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: enteral. Current US regulatory status: approved.
Key facts
INN carbidopa
Brand CARBIDOPA AND LEVODOPA
Route ENTERAL
Formulation TABLET, ORALLY DISINTEGRATING
Frequently asked questions
What is carbidopa?
carbidopa (CARBIDOPA AND LEVODOPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: enteral. Current US regulatory status: approved.
What is the brand name for carbidopa?
CARBIDOPA AND LEVODOPA is a marketed brand name for carbidopa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carbidopa?
carbidopa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.